skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 23,997  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: subject: Clinical Trials remove subject: Medical Research remove subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The Structure of Clinical Translation: Efficiency, Information, and Ethics
The Structure of Clinical Translation: Efficiency, Information, and Ethics
Material Type:
Article 		Add to My Research

The Structure of Clinical Translation: Efficiency, Information, and Ethics

The Hastings Center report, 2015-03, Vol.45 (2), p.27-39 [Peer Reviewed Journal]

2015 The Hastings Center ;Copyright Blackwell Publishing Ltd. Mar-Apr 2015 ;ISSN: 0093-0334 ;EISSN: 1552-146X ;DOI: 10.1002/hast.433 ;PMID: 25628068 ;CODEN: HSCRAS

Full text available

Citations Cited by
2
Patients’ roles and rights in research
Patients’ roles and rights in research
Material Type:
Article 		Add to My Research

Patients’ roles and rights in research

BMJ (Online), 2018-07, Vol.362, p.k3193-k3193 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2018BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.k3193 ;PMID: 30045909

Full text available

Citations Cited by
3
Stakeholders welcome proposal on the European Health Data Space
Stakeholders welcome proposal on the European Health Data Space
Material Type:
Article 		Add to My Research

Stakeholders welcome proposal on the European Health Data Space

The lancet oncology, 2022-12, Vol.23 (12), p.1492-1492 [Peer Reviewed Journal]

2022 Elsevier Ltd ;2022. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(22)00691-X ;PMID: 36335972

Full text available

Citations Cited by
4
Human tissues in a dish: The research and ethical implications of organoid technology
Human tissues in a dish: The research and ethical implications of organoid technology
Material Type:
Article 		Add to My Research

Human tissues in a dish: The research and ethical implications of organoid technology

Science (American Association for the Advancement of Science), 2017-01, Vol.355 (6322), p.260-260 [Peer Reviewed Journal]

Copyright © 2017 American Association for the Advancement of Science ;Copyright © 2017, American Association for the Advancement of Science. ;Copyright © 2017, American Association for the Advancement of Science ;ISSN: 0036-8075 ;EISSN: 1095-9203 ;DOI: 10.1126/science.aaf9414 ;PMID: 28104841

Digital Resources/Online E-Resources

Citations Cited by
5
The importance of patient-reported outcomes in clinical trials and strategies for future optimization
The importance of patient-reported outcomes in clinical trials and strategies for future optimization
Material Type:
Article 		Add to My Research

The importance of patient-reported outcomes in clinical trials and strategies for future optimization

Patient related outcome measures, 2018-01, Vol.9, p.353-367 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Mercieca-Bebber et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1179-271X ;EISSN: 1179-271X ;DOI: 10.2147/prom.s156279 ;PMID: 30464666

Full text available

Citations Cited by
6
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
Material Type:
Article 		Add to My Research

Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial

The lancet oncology, 2021-08, Vol.22 (8), p.1162-1174 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00302-8

Full text available

Citations Cited by
7
Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses
Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses
Material Type:
Article 		Add to My Research

Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses

Canadian Medical Association journal (CMAJ), 2020-08, Vol.192 (32), p.E901-E906 [Peer Reviewed Journal]

2020 Joule Inc. or its licensors. ;COPYRIGHT 2020 Joule Inc. ;Copyright Joule Inc Aug 10, 2020 ;2020 Joule Inc. or its licensors 2020 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.200077 ;PMID: 32778601

Full text available

Citations Cited by
8
Raise standards for preclinical cancer research
Raise standards for preclinical cancer research
Material Type:
Article 		Add to My Research

Raise standards for preclinical cancer research

Nature (London), 2012-03, Vol.483 (7391), p.531-533 [Peer Reviewed Journal]

Copyright Nature Publishing Group Mar 29, 2012 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/483531a ;CODEN: NATUAS

Full text available

Citations Cited by
9
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Material Type:
Article 		Add to My Research

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

The Lancet (British edition), 2011-06, Vol.377 (9783), p.2103-2114 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 18-Jun 24, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60613-2 ;PMID: 21641636 ;CODEN: LANCAO

Full text available

Citations Cited by
10
A living WHO guideline on drugs for covid-19
A living WHO guideline on drugs for covid-19
Material Type:
Article 		Add to My Research

A living WHO guideline on drugs for covid-19

BMJ (Online), 2020-09, Vol.370, p.m3379-m3379 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m3379 ;PMID: 32887691

Full text available

Citations Cited by
11
A decade of immune-checkpoint inhibitors in cancer therapy
A decade of immune-checkpoint inhibitors in cancer therapy
Material Type:
Article 		Add to My Research

A decade of immune-checkpoint inhibitors in cancer therapy

Nature communications, 2020-07, Vol.11 (1), p.3801-3801, Article 3801 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-17670-y ;PMID: 32732879

Full text available

Citations Cited by
12
Are innovation and new technologies in precision medicine paving a new era in patients centric care?
Are innovation and new technologies in precision medicine paving a new era in patients centric care?
Material Type:
Article 		Add to My Research

Are innovation and new technologies in precision medicine paving a new era in patients centric care?

Journal of translational medicine, 2019-04, Vol.17 (1), p.114-114, Article 114 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 1479-5876 ;EISSN: 1479-5876 ;DOI: 10.1186/s12967-019-1864-9 ;PMID: 30953518

Full text available

Citations Cited by
13
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
Material Type:
Article 		Add to My Research

The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors

Nature reviews. Drug discovery, 2018-11, Vol.17 (12), p.854-855 [Peer Reviewed Journal]

Copyright Nature Publishing Group Dec 2018 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2018.210

Full text available

Citations Cited by
14
Epithelial ovarian cancer
Epithelial ovarian cancer
Material Type:
Article 		Add to My Research

Epithelial ovarian cancer

The Lancet (British edition), 2019-03, Vol.393 (10177), p.1240-1253 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32552-2 ;PMID: 30910306

Full text available

Citations Cited by
15
WHO, WHAT AND WHERE IS THE CLINICAL TRANSLATIONAL RESEARCH CENTER
WHO, WHAT AND WHERE IS THE CLINICAL TRANSLATIONAL RESEARCH CENTER
Material Type:
Article 		Add to My Research

WHO, WHAT AND WHERE IS THE CLINICAL TRANSLATIONAL RESEARCH CENTER

Oncology nursing forum, 2022-03, Vol.49 (2), p.E134-E135 [Peer Reviewed Journal]

Copyright Oncology Nursing Society Mar 2022 ;ISSN: 0190-535X ;EISSN: 1538-0688

Full text available

Citations Cited by
16
Adaptive platform trials: definition, design, conduct and reporting considerations
Adaptive platform trials: definition, design, conduct and reporting considerations
Material Type:
Article 		Add to My Research

Adaptive platform trials: definition, design, conduct and reporting considerations

Nature reviews. Drug discovery, 2019-10, Vol.18 (10), p.797-807 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2019 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/s41573-019-0034-3 ;PMID: 31462747

Full text available

Citations Cited by
17
Patient and public involvement in biomedical research: training is not a substitute for relationship building
Patient and public involvement in biomedical research: training is not a substitute for relationship building
Material Type:
Article 		Add to My Research

Patient and public involvement in biomedical research: training is not a substitute for relationship building

Annals of the rheumatic diseases, 2019-11, Vol.78 (11), p.1607-1608 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2019-215595 ;PMID: 31300462

Full text available

Citations Cited by
18
Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial
Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial
Material Type:
Article 		Add to My Research

Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial

The Lancet (British edition), 2011-03, Vol.377 (9768), p.823-836 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;2011. Elsevier Ltd ;Copyright Elsevier Limited Mar 5-Mar 11, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60096-2 ;PMID: 21334061 ;CODEN: LANCAO

Full text available

Citations Cited by
19
Dementia in China: epidemiology, clinical management, and research advances
Dementia in China: epidemiology, clinical management, and research advances
Material Type:
Article 		Add to My Research

Dementia in China: epidemiology, clinical management, and research advances

Lancet neurology, 2020-01, Vol.19 (1), p.81-92 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(19)30290-X ;PMID: 31494009

Full text available

Citations Cited by
20
Discrimination and Calibration of Clinical Prediction Models: Users' Guides to the Medical Literature
Discrimination and Calibration of Clinical Prediction Models: Users' Guides to the Medical Literature
Material Type:
Article 		Add to My Research

Discrimination and Calibration of Clinical Prediction Models: Users' Guides to the Medical Literature

JAMA : the journal of the American Medical Association, 2017-10, Vol.318 (14), p.1377 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2017.12126 ;PMID: 29049590

Digital Resources/Online E-Resources

Citations Cited by

Results 1 - 20 of 23,997  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1983  (20)
  2. 1983 To 1992  (76)
  3. 1993 To 2002  (404)
  4. 2003 To 2013  (2,457)
  5. After 2013  (21,043)
  6. More options open sub menu

Subject 

  1. Science & Technology  (10,476)
  2. Life Sciences & Biomedicine  (8,622)
  3. Humans  (6,703)
  4. Cancer Therapies  (6,036)
  5. Oncology  (5,526)
  6. Tumors  (4,795)
  7. Cancer  (4,491)
  8. Medicine, Experimental  (4,481)
  9. Care And Treatment  (3,204)
  10. R&d  (3,133)
  11. Research & Development  (3,133)
  12. Female  (3,094)
  13. Drug Dosages  (3,021)
  14. Hospitals  (2,975)
  15. Collaboration  (2,852)
  16. Metastasis  (2,849)
  17. Chemotherapy  (2,831)
  18. More options open sub menu

Language 

  1. English  (23,984)
  2. Japanese  (996)
  3. Norwegian  (19)
  4. Portuguese  (18)
  5. French  (9)
  6. Chinese  (6)
  7. Russian  (4)
  8. German  (4)
  9. Urdu  (4)
  10. Turkish  (4)
  11. Persian  (3)
  12. Italian  (2)
  13. Spanish  (2)
  14. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait